Cargando…

Variations in MHC class I antigen presentation and immunopeptidome selection pathways

Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaitouna, Anita J., Kaur, Amanpreet, Raghavan, Malini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525337/
https://www.ncbi.nlm.nih.gov/pubmed/33014341
http://dx.doi.org/10.12688/f1000research.26935.1
_version_ 1783588725879472128
author Zaitouna, Anita J.
Kaur, Amanpreet
Raghavan, Malini
author_facet Zaitouna, Anita J.
Kaur, Amanpreet
Raghavan, Malini
author_sort Zaitouna, Anita J.
collection PubMed
description Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I variations permit the display of thousands of distinct peptides at the cell surface. Recent mass spectrometric studies have revealed unique and shared characteristics of the peptidomes of individual MHC-I variants. The cell surface expression of MHC-I–peptide complexes requires the functions of many intracellular assembly factors, including the transporter associated with antigen presentation (TAP), tapasin, calreticulin, ERp57, TAP-binding protein related (TAPBPR), endoplasmic reticulum aminopeptidases (ERAPs), and the proteasomes. Recent studies provide important insights into the structural features of these factors that govern MHC-I assembly as well as the mechanisms underlying peptide exchange. Conformational sensing of MHC-I molecules mediates the quality control of intracellular MHC-I assembly and contributes to immune recognition by CD8 at the cell surface. Recent studies also show that several MHC-I variants can follow unconventional assembly routes to the cell surface, conferring selective immune advantages that can be exploited for immunotherapy.
format Online
Article
Text
id pubmed-7525337
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-75253372020-10-01 Variations in MHC class I antigen presentation and immunopeptidome selection pathways Zaitouna, Anita J. Kaur, Amanpreet Raghavan, Malini F1000Res Review Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I variations permit the display of thousands of distinct peptides at the cell surface. Recent mass spectrometric studies have revealed unique and shared characteristics of the peptidomes of individual MHC-I variants. The cell surface expression of MHC-I–peptide complexes requires the functions of many intracellular assembly factors, including the transporter associated with antigen presentation (TAP), tapasin, calreticulin, ERp57, TAP-binding protein related (TAPBPR), endoplasmic reticulum aminopeptidases (ERAPs), and the proteasomes. Recent studies provide important insights into the structural features of these factors that govern MHC-I assembly as well as the mechanisms underlying peptide exchange. Conformational sensing of MHC-I molecules mediates the quality control of intracellular MHC-I assembly and contributes to immune recognition by CD8 at the cell surface. Recent studies also show that several MHC-I variants can follow unconventional assembly routes to the cell surface, conferring selective immune advantages that can be exploited for immunotherapy. F1000 Research Limited 2020-09-28 /pmc/articles/PMC7525337/ /pubmed/33014341 http://dx.doi.org/10.12688/f1000research.26935.1 Text en Copyright: © 2020 Zaitouna AJ et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Zaitouna, Anita J.
Kaur, Amanpreet
Raghavan, Malini
Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title_full Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title_fullStr Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title_full_unstemmed Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title_short Variations in MHC class I antigen presentation and immunopeptidome selection pathways
title_sort variations in mhc class i antigen presentation and immunopeptidome selection pathways
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525337/
https://www.ncbi.nlm.nih.gov/pubmed/33014341
http://dx.doi.org/10.12688/f1000research.26935.1
work_keys_str_mv AT zaitounaanitaj variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways
AT kauramanpreet variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways
AT raghavanmalini variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways